Search

Author/Creator Yarnall, David

1. A genetic enrichment strategy for delay of onset of Alzheimer's disease clinical trials: Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation. (7th December 2020)

Authors:
Lutz, Michael W.; Burns, Daniel K.; Alexander, Robert; Culp, Meredith; Yarnall, David; Haneline, Stephen; Chiang, Carl; Lai, Eric; Metz, Craig; Sundseth, Scott; Guennel, Tobi; Marshall, Scott; Andruss, Bernard F.; Latham, Gary J.; Hall, Bradley; Statt, Sarah N.; Swanson, Tom; Ratti, Emiliangelo; ...
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 5
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P2‐083: Progress in the tommorrow study: A pharmacogenetics supported clinical trial to delay onset of mild cognitive impairment due to Alzheimer's disease with low‐dose pioglitazone. (1st July 2015)

Authors:
Budur, Kumar; Welsh-Bohmer, Kathleen; Burns, Daniel K.; Chiang, Carl; O'Neil, Janet; Runyan, Grant; Culp, Meredith; Crenshaw, Donna G.; Lutz, Michael W.; Metz, Craig A.; Saunders, Ann M.; Yarbrough, Deborah; Yarnall, David; Lai, Eric; Brannan, Stephen K.; Roses, Allen D.
Journal:
Alzheimer's & dementia
Issue:
Volume 11(2015)Supplement 7S:Part 11
Page Start:
P515
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P4‐073: A PHARMACOGENETICS‐SUPPORTED CLINICAL TRIAL TO DELAY ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE USING LOW‐DOSE PIOGLITAZONE: AN UPDATE ON THE TOMORROW STUDY. (1st July 2014)

Authors:
Budur, Kumar; Welsh‐Bohmer, Kathleen; Burns, Daniel; Chiang, Carl; O'Neil, Janet; Runyan, Grant; Cyganowski, Marcia; Crenshaw, Donna G.; Lutz, Michael W.; Metz, Craig; Saunders, Ann; Yarbrough, Deborah; Yarnall, David; Lai, Eric; Brannan, Stephen; Roses, Allen D.
Journal:
Alzheimer's & dementia
Issue:
Volume 10:Supplement 4S(2014)Part 22
Page Start:
P809
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P4‐383: Characterization of the Screened Population for the Tommorrow Study: a Pharmacogenetics‐Supported Clinical Trial to Delay the Onset of Mild Cognitive Impairment Due to Alzheimer'S Disease. (1st July 2016)

Authors:
Martenyi, Ferenc; Welsh-Bohmer, Kathleen A.; Plassman, Brenda L.; Harrigan, Patrick; Chiang, Carl; O'Neil, Janet; Runyan, Grant; Culp, Meredith; Lutz, Michael W.; Lai, Eric; Saunders, Ann M.; Haneline, Stephen; Yarnall, David; Yarbrough, Deborah; Metz, Craig; Burns, Daniel K.; Roses, Allen D.
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2014)Part 24
Page Start:
P1184
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The TOMMORROW study: Design of an Alzheimer's disease delay‐of‐onset clinical trial. Issue 1 (1st January 2019)

Authors:
Burns, Daniel K.; Chiang, Carl; Welsh‐Bohmer, Kathleen A.; Brannan, Stephen K.; Culp, Meredith; O'Neil, Janet; Runyan, Grant; Harrigan, Patrick; Plassman, Brenda L.; Lutz, Michael; Lai, Eric; Haneline, Stephen; Yarnall, David; Yarbrough, Deborah; Metz, Craig; Ponduru, Sridevi; Sundseth, Scott; Sa...
Journal:
Alzheimer's & dementia
Issue:
Volume 5:Issue 1(2019)
Page Start:
661
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗